According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that:
- Brainstorm Cell downplayed the severity of the U.S. Food and Drug Administration’s (“FDA”) refusal to file letter;
- Brainstorm Cell continued to conceal the risks associated with the submission of the biologics license application (“BLA”); and
- as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Attorney Advertising. Prior results do not guarantee a similar outcome.